Composition comprising azole fungicide and water soluble metal salt

Information

  • Patent Grant
  • 8759385
  • Patent Number
    8,759,385
  • Date Filed
    Tuesday, April 13, 2010
    14 years ago
  • Date Issued
    Tuesday, June 24, 2014
    10 years ago
Abstract
Hair treatment composition comprising an azole fungicide and zinc gluconate and wherein the composition does not comprise Trichogen®.
Description

The present invention relates to compositions for treating or preventing hair fall.


Despite the prior art there remains a need for improved compositions for treating or preventing hair fall.


Accordingly, there is provided a hair treatment composition comprising an azole fungicide and zinc gluconate, and wherein the composition does not comprise Trichogen® Veg LS 8960.


Preferably, the azole fungicide is climabazole or ketoconazole.


Preferably, the azole is present at from 0.0001 to 1% wt. of the composition.


Preferably, the zinc gluconate is present at from 0.001 to 2% wt. of the composition. More preferably, the composition comprises from 0.005 to 1% wt. of the composition.


Preferably, the composition does not comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promotor and mixtures thereof.


Preferably the composition does not comprises a synergistic trichogenic mixture of a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts, particularly sulfopeptides of soy and amino acids, especially tyrosine, arginine, ornithine and citrulline. Preferably, the composition does not comprise a glycosamino production agent selected from the group consisting of glucosamine, L-fucose; fucose rich polysaccharide, xylose, vitamin C, Eriobotrya japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof. Particularly preferred is glucosamine.


Preferably, the composition does not comprise a cell nutrition regulator especially vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof. Particularly preferred are vitamins of the B group, especially PP, B5 and biotin.


Preferably, the composition does not comprise a microcirculation promoter, more preferably a microcirculation promoter selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.


Preferably, the composition does not comprise a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.


Preferably, the composition does not comprise a glycosamino production agent selected from glucosamine, L-fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.


Preferably, the composition does not comprise a cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.


Preferably, the composition does not comprise a microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.


Most preferably, the composition does not comprise Trichogen® ex Cognis, in particular Trichogen® Veg LS 8960.


Trichogen® Veg LS 8960. contains:



Panax Ginseng Root Extract, Arginine, Acetyl Tyrosine, Arctium Majus Root Extract, Hydrolysed Soy Protein, Zinc gluconate, Niacinamide, Biotin, Salvia Sclarea Extract, Cinnamomumb Zeylanicum Extract, Ginko Biloba Extract and Kigela Africanal Extract.


The composition according to the invention may be in any product form, e.g. shampoo, mousse, conditioner, gel, mask and may be a rinse-off product or a leave-on product.


Depending on product form the composition according to the invention may also comprise any common ingredients typically found in such product form. For example, a shampoo will likely comprise cleansing surfactants; a conditioner will comprise conditioning agents selected from fatty alcohols, silicone and cationic surfactants, etc.


The invention will now be described with reference to the following embodiments.







EXAMPLE 1

The following are formulations according to embodiments of the invention.


Leave-on formulations




















A
B
C
D
E
F






















Water and
To
To
To
To
To
To


minors
100%
100%
100%
100%
100%
100%


Natrosol
1.00
1.00
1.00
1.00
1.00
1.00


250HHR


Glycerol
5.00
5.00
5.00
5.00
5.00
5.00


Zinc
0.1
0.1
0.05
0.05
0.001
0.006


gluconate


Climbazole
0.02
0.001
0.02
0.001
0.008
0.06


Ethanol
1.0
1.0
1.0
1.0
1.0
1.0









Shampoo examples


















Water and minors
To 100%
To 100%
To 100%
To 100%


Climbazole
0.5
0.5
0.5
0.5


Zinc gluconate
1.0
0.8
0.4
0.5


Texapon N70
7.70
7.70
7.70
7.70


Mackanate EL
12.50
12.50
12.50
12.50


Tegobetaine
9.60
9.60
9.60
9.60


Jaguar C13S
0.15
0.15
0.15
0.15


Jaguar C17
0.05
0.05
0.05
0.05


Sodium Hydroxide
0.05
0.05
0.05
0.05


(50%)









Conditioners



















Water
To 100%
To 100%



Lexamine S13
1.25
1.25



Ganamin BTLF
1.25
1.25



Laurex CS
5.00
5.00



Potassium Chloride
0.10
0.10



EDTA
0.10
0.10



Lauric Acid
0.30
0.30



Zinc gluconate
1.0
1.0



Climbazole
0.5
0.2



Propylene glycol
2.0
2.0










EXAMPLE 2

The following shows how zinc gluconate and climbazole provide an improved anti-trypsin effect.


1. Zinc Gluconate (0.00156%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
1.03
1.03
1.03
1.03
1.03
1.03


gluconate


(0.00156%)


Calculated
1.045
0.969
1.165
1.22
1.17
1.09


efficacy


Experimental
0.935
0.88
0.32
0.49
0.75
0.93


efficacy


(synergy)









2. Zinc Gluconate (0.003125%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
0.957
0.957
0.957
0.957
0.957
0.957


gluconate


(0.003125%)


Calculated
1.01
0.9325
1.1285
1.1835
1.1335
1.0535


efficacy


Experimental
0.87
0.88
0.24
0.27
0.61
0.83


efficacy


(synergy)









3. Zinc Gluconate (0.00625%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
0.8404
0.8404
0.8404
0.8404
0.8404
0.8404


gluconate


(0.00625%)


Calculated
0.95
0.874
1.07
1.125
1.075
0.995


efficacy


Experimental
0.753
1.10
0.328
0.037
0.384
0.578


efficacy


(synergy)








Claims
  • 1. Hair treatment composition comprising climbazole and zinc gluconate and wherein the composition does not comprise a mixture of Panax Ginseng Root Extract, Arginine, Acetyl Tyrosine, Arctium Majus Root Extract, Hydrolysed Soy Protein, Zinc gluconate, Niacinamide, Biotin, Salvia Sclarea Extract, Cinnamomumb Zeylanicum Extract, Ginko Biloba Extract and Kigela Africana Extract; wherein the zinc gluconate and climbazole are present in amounts sufficient to synergistically inhibit trypsin;wherein the climbs is present at 0.0001 to 1% by wt. of the composition and the zinc gluconate is present at 0.001 to 0.00625% by wt. of the composition.
Priority Claims (1)
Number Date Country Kind
09158655 Apr 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2010/054815 4/13/2010 WO 00 10/17/2011
Publishing Document Publishing Date Country Kind
WO2010/121922 10/28/2010 WO A
US Referenced Citations (5)
Number Name Date Kind
4652445 Ort Mar 1987 A
6284234 Niemiec et al. Sep 2001 B1
8506942 Burry et al. Aug 2013 B2
20020102228 Dunlop et al. Aug 2002 A1
20090285865 Shalaby Nov 2009 A1
Foreign Referenced Citations (6)
Number Date Country
102006037113 Feb 2008 DE
0489581 Jun 1992 EP
0674897 Oct 1995 EP
WO 0066072 Nov 2000 WO
WO0207700 Jan 2002 WO
WO 2005046629 May 2005 WO
Non-Patent Literature Citations (6)
Entry
Tim Faber, Trichogen Complex—Stop Hair Loss and Promote Hair Growth.placeHolder, Ezine Articles, Jun. 3, 2008, Internet Pulication Online, p. 1-p. 2.
PCT International Search Report in PCT Application PCT/EP2010/054815, mailed on Apr. 10, 2010.
EP Search Report in EP Application EP 09 15 8655, dated Sep. 23, 2009.
PCT International Written Opinion in PCT Application PCT/EP2010/054802, (Oct. 25, 2011).
PCT International Written Opinion in PCT Application PCT/EP2010/054815.
Milner et al., Exogen, Shedding Phase of the Hair Growth Cycle: Characterization of a Mouse Model, Journal of Investigative Dermatology, Sep. 2002, 639-644, vol. 119 No. 3.
Related Publications (1)
Number Date Country
20120035186 A1 Feb 2012 US